Fundamental Analysis of Glenmark Life Sciences – Future Plans & More
Trade Brains
JULY 23, 2023
traces its origins to 2001 when its parent company Glenmark Pharmaceuticals Ltd. This can be gauged from the fact that the nation accounts for the most number of DMFs applied in the United States at 15%. Glenmark plans to commission the recently finished 240 KL CAPEX project for its API and Oncology facility soon.
Let's personalize your content